SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
06-Jan-23 5:16 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 05-Jan-23 | Sale | 3,392 | $1.13 | $3,830.21 | (1%) 268.91K to 265.51K | |
06-Jan-23 5:16 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 04-Jan-23 | Sale | 6,392 | $1.13 | $7,246.68 | (2%) 275.3K to 268.91K | |
04-Jan-23 5:01 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 02-Jan-23 | Grant | 100,000 | -- | -- | 57% 175.3K to 275.3K | |
07-Jan-22 4:18 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 05-Jan-22 | Market Sale | 3,416 | $3.09 | $10,541.40 | (2%) 178.72K to 175.3K | 6% |
05-Jan-22 4:33 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 03-Jan-22 | Grant | 72,000 | -- | -- | 67% 106.72K to 178.72K | |
14-Dec-21 5:16 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 10-Dec-21 | Market Sale | 4,370 | $2.99 | $13,052.80 | (4%) 111.08K to 106.72K | (3%) |
10-Dec-21 5:07 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 08-Dec-21 | Grant | 13,750 | -- | -- | 14% 97.33K to 111.08K | |
15-Oct-21 6:07 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 13-Oct-21 | Market Sale | 3,892 | $4.39 | $17,085.90 | (4%) 101.23K to 97.33K | 1% |
05-Oct-21 4:26 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 01-Oct-21 | Grant | 13,750 | -- | -- | 16% 87.48K to 101.23K | |
19-Mar-21 5:33 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 17-Mar-21 | Market Sale | 15,128 | $4.45 | $67,312.00 | (15%) 102.61K to 87.48K | 1% |
16-Feb-21 6:10 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 11-Feb-21 | Option Exercise | 44,871 | $0.63 | $28,268.70 | 78% 57.73K to 102.61K | |
06-Jan-21 4:49 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 04-Jan-21 | Grant | 38,000 | -- | -- | 193% 19.73K to 57.73K | |
21-Jan-20 5:21 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 16-Jan-20 | Option Exercise | 5,128 | $0.47 | $2,410.16 | 44% 11.61K to 16.73K | |
25-Jul-19 4:15 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 23-Jul-19 | Option Exercise | 10,000 | $0.47 | $4,700.00 | 623% 1.61K to 11.61K | |
06-Jul-17 4:05 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 03-Jul-17 | Option Exercise | 5,959 | $2.77 | $16,506.40 | 371% 1.61K to 7.57K | |
06-Jul-17 4:05 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 03-Jul-17 | Market Option Sale (Planned) | 5,959 | $19.10 | $113,806.00 | (79%) 7.57K to 1.61K | 83% |
19-Jun-17 4:12 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 15-Jun-17 | Option Exercise | 20,512 | $0.47 | $9,640.64 | 1277% 1.61K to 22.12K | |
19-Jun-17 4:12 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 15-Jun-17 | Market Option Sale (Planned) | 20,512 | $17.00 | $348,640.00 | (93%) 22.12K to 1.61K | 81% |
18-Apr-17 5:18 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 17-Apr-17 | Option Exercise | 13,205 | $0.39 | $5,149.95 | 822% 1.61K to 14.81K | |
18-Apr-17 5:18 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 17-Apr-17 | Market Option Sale (Planned) | 13,205 | $13.95 | $184,210.00 | (89%) 14.81K to 1.61K | 77% |
30-Jan-17 4:54 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 23-Jan-17 | Option Exercise | 15,000 | $0.39 | $5,850.00 | 934% 1.61K to 16.61K | |
30-Jan-17 4:54 PM View: | Cartesian Therapeutics, Inc. (RNAC) | 23-Jan-17 | Market Option Sale (Planned) | 15,000 | $14.01 | $210,106.00 | (90%) 16.61K to 1.61K | 77% |